Unicon Optical Co., Ltd.
Unicon Optical Co., Ltd. researches, develops, designs, manufactures, and sells contact lenses in Taiwan. The company offers basic blue tint, color, and silicon hydrogel lenses under the brand name UNICON. The company was founded in 1992 and is headquartered in Hsinchu City, Taiwan.
Unicon Optical Co., Ltd. (4150) - Net Assets
Latest net assets as of June 2025: NT$629.35 Million TWD
Based on the latest financial reports, Unicon Optical Co., Ltd. (4150) has net assets worth NT$629.35 Million TWD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$1.12 Billion) and total liabilities (NT$492.92 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$629.35 Million |
| % of Total Assets | 56.08% |
| Annual Growth Rate | -19.52% |
| 5-Year Change | 39.64% |
| 10-Year Change | N/A |
| Growth Volatility | 51.95 |
Unicon Optical Co., Ltd. - Net Assets Trend (2019–2024)
This chart illustrates how Unicon Optical Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Unicon Optical Co., Ltd. (2019–2024)
The table below shows the annual net assets of Unicon Optical Co., Ltd. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$767.42 Million | -20.33% |
| 2023-12-31 | NT$963.23 Million | +39.90% |
| 2022-12-31 | NT$688.49 Million | -26.77% |
| 2021-12-31 | NT$940.14 Million | +71.06% |
| 2020-12-31 | NT$549.59 Million | -75.84% |
| 2019-12-31 | NT$2.27 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Unicon Optical Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 13552300000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | NT$1.47 Billion | 191.83% |
| Other Comprehensive Income | NT$2.91 Million | 0.38% |
| Other Components | NT$8.00 Million | 1.04% |
| Total Equity | NT$767.42 Million | 100.00% |
Unicon Optical Co., Ltd. Competitors by Market Cap
The table below lists competitors of Unicon Optical Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MERUS POWER OYJ EO 1
F:99H
|
$22.69 Million |
|
Chaman Lal Setia Exports Limited
NSE:CLSEL
|
$22.70 Million |
|
Valiant Organics Limited
NSE:VALIANTORG
|
$22.70 Million |
|
MIND CTI Ltd
NASDAQ:MNDO
|
$22.72 Million |
|
Gadang Holdings Bhd
KLSE:9261
|
$22.68 Million |
|
Warteck Invest AG Reg.
LSE:0QNK
|
$22.68 Million |
|
KODAL MINERALS LS-03125
F:7UE
|
$22.68 Million |
|
ADVENICA AB
F:65R
|
$22.63 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Unicon Optical Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 963,228,000 to 767,422,000, a change of -195,806,000 (-20.3%).
- Net loss of 174,148,000 reduced equity.
- Other comprehensive income increased equity by 8,862,000.
- Other factors decreased equity by 30,520,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$-174.15 Million | -22.69% |
| Other Comprehensive Income | NT$8.86 Million | +1.15% |
| Other Changes | NT$-30.52 Million | -3.98% |
| Total Change | NT$- | -20.33% |
Book Value vs Market Value Analysis
This analysis compares Unicon Optical Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.27x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.65x to 1.27x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | NT$10.10 | NT$6.60 | x |
| 2020-12-31 | NT$6.36 | NT$6.60 | x |
| 2021-12-31 | NT$6.54 | NT$6.60 | x |
| 2022-12-31 | NT$4.68 | NT$6.60 | x |
| 2023-12-31 | NT$6.46 | NT$6.60 | x |
| 2024-12-31 | NT$5.21 | NT$6.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Unicon Optical Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -22.69%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -19.15%
- • Asset Turnover: 0.71x
- • Equity Multiplier: 1.67x
- Recent ROE (-22.69%) is above the historical average (-25.35%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -18.41% | -12.86% | 0.52x | 2.76x | NT$-245.30 Million |
| 2020 | -64.55% | -31.86% | 0.56x | 3.63x | NT$-409.74 Million |
| 2021 | -31.19% | -32.65% | 0.46x | 2.09x | NT$-387.25 Million |
| 2022 | -36.84% | -30.73% | 0.50x | 2.39x | NT$-322.48 Million |
| 2023 | 21.57% | 24.56% | 0.55x | 1.59x | NT$111.42 Million |
| 2024 | -22.69% | -19.15% | 0.71x | 1.67x | NT$-250.89 Million |
Industry Comparison
This section compares Unicon Optical Co., Ltd.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,888,693,889
- Average return on equity (ROE) among peers: 9.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Unicon Optical Co., Ltd. (4150) | NT$629.35 Million | -18.41% | 0.78x | $22.68 Million |
| St.Shine Optical Co Ltd (1565) | $5.39 Billion | 29.48% | 0.60x | $147.19 Million |
| Nang Kuang Pharmaceutical Co Ltd (1752) | $2.19 Billion | 9.94% | 0.50x | $46.91 Million |
| Maxigen Biotech Inc (1783) | $1.14 Billion | 7.68% | 0.11x | $53.63 Million |
| SciVision Biotech Inc (1786) | $1.02 Billion | -2.16% | 0.07x | $107.95 Million |
| Bioteque (4107) | $1.88 Billion | 15.46% | 0.25x | $198.92 Million |
| Chi Sheng Chemical (4111) | $1.22 Billion | 12.60% | 0.47x | $41.85 Million |
| Sunder Biomedical Tech. Co., Ltd. (4115) | $790.45 Million | 1.68% | 0.80x | $2.11K |
| BenQ Medical Technology (4116) | $1.10 Billion | 2.62% | 0.78x | $25.45 Million |
| Pacific Hospital Supply Co Ltd (4126) | $2.26 Billion | 10.49% | 0.61x | $128.74 Million |